Anesthesia and analgesia
-
Anesthesia and analgesia · Jun 1998
Comparative StudyThe pharmacokinetics of vecuronium in male and female patients.
To evaluate the effect of gender on the pharmacokinetics of vecuronium, we studied 30 patients (15 male and 15 female) undergoing elective plastic surgery with anticipated surgical blood loss of <300 mL under general anesthesia. General anesthesia was induced with thiopental 4-6 mg/kg and fentanyl 2-4 microg/kg and was maintained with 60% nitrous oxide in oxygen and an end-tidal concentration of 1.5%-2% enflurane. After a 2-min infusion of vecuronium 100 microg/kg, a modified fluorometric assay was used to determine the plasma concentrations of vecuronium for 5 h. The results showed that, compared with women, the plasma concentrations of vecuronium in men were significantly lower during the first 20 min and that the disposition kinetics of vecuronium can be best described mathematically by a three-compartment open model in the two groups. The volume of the central compartment and the volume of distribution at steady state were 39.6 +/- 8.6 and 164.8 +/- 29.3 mL/kg, respectively, in women. These values increased significantly to 54.4 +/- 14.4 and 201.4 +/- 75.8 mL/kg in men (P < 0.05). When the data were calculated on the basis of ideal body weight, the volume of distribution of vecuronium was also different between men and women (P < 0.05. The half-lives of fast distribution and distribution, the elimination half-life, mean residual time, area under the plasma-concentration curve, and plasma clearance were not different between the two groups. We conclude that the pharmacokinetics of vecuronium are significantly different between genders and that and men have the greater volume of distribution of vecuronium. ⋯ The authors found that, compared with women, men had lower plasma concentrations of vecuronium after the i.v. administration of vecuronium and a larger volume of distribution of vecuronium. The pharmacokinetic differences may be related to the differences in the sensitivity to vecuronium between genders.
-
Anesthesia and analgesia · Jun 1998
Comparative StudyRapid development of tolerance to analgesia during remifentanil infusion in humans.
Studies in experimental animals have demonstrated a rapidly developing acute tolerance to the analgesic effect of opioids administered by continuous i.v. infusion. The aim of the present study was to determine whether acute tolerance plays an important role in the analgesic effect of remifentanil provided by i.v. infusion to humans. The analgesic effect of remifentanil, infused at a constant rate of 0.1 microg x kg(-1) x min(-1) for 4 h, was evaluated by measuring pain tolerance with thermal (2 degrees C water) and mechanical (pressure) noxious stimulations in 13 paid volunteers. The constant-rate infusion of remifentanil resulted in a threefold increase in pain tolerance with both tests. After reaching its maximum in 60-90 min, the analgesic effect of remifentanil began to decline despite the constant-rate infusion, and after 3 h of infusion, it was only one fourth of the peak value. A comparative rate in the development of acute tolerance measured in terms of time to 50% recovery during infusion was 129 +/- 27 min (mean +/- SD) with the cold water test and 138 +/- 39 min with the pressure test. We conclude that the development of tolerance should be included in the calculations for target-controlled infusions. ⋯ Our study shows that tolerance to analgesia during remifentanil infusion is profound and develops very rapidly. The administration of opioids during anesthesia based on target-controlled infusions should include corrections for the development of tolerance.
-
Anesthesia and analgesia · Jun 1998
Unplanned tracheal extubation outside the operating room: a quality improvement audit of hemodynamic and tracheal airway complications associated with emergency tracheal reintubation.
The incidence of hemodynamic and airway complications associated with tracheal reintubation after an unplanned extubation has not been established. Patients whose tracheas were emergently intubated outside the operating room were reviewed over a 27-mo period via a quality improvement vehicle to evaluate hemodynamic and airway complications. Data from a subset of patients (n = 57) who underwent tracheal reintubation after unplanned (self-) extubation were collected for analysis. Of the reintubations, 93% took place within 2 h of self-extubation. Of the patients, 72% had hemodynamic alterations and/or airway-related complications, including hypotension (35%), tachycardia (30%), hypertension (14%), multiple laryngoscopic attempts (22%), difficult laryngoscopy (16%), difficult intubations (14%), hypoxemia (14%), and esophageal intubation (14%). In addition, one surgical airway and one case of "cannot ventilate, cannot intubate" leading to cardiac arrest and death were recorded. These findings suggest that patients requiring reintubation will likely do so soon after self-extubation and that reintubation can be fraught with significant hemodynamic and airway complications. Less than one third of patients undergo a mishap-free reintubation. Strategies to decrease the self-extubation rate in the intensive care unit are needed to improve patient safety and to lessen the potential impact of emergency airway management. ⋯ Self-extubation by patients requiring mechanical ventilation can be life-threatening, and replacing the breathing tube often leads to hemodynamic and airway complications. Using this quality improvement audit, 57 self-extubating patients and the complications associated with replacing the breathing tube, which are numerous and can lead to significant morbidity and mortality, were analyzed.
-
Anesthesia and analgesia · Jun 1998
A new and simple maneuver to position the left-sided double-lumen tube without the aid of fiberoptic bronchoscopy.
The double-lumen tube (DLT) is the mainstay of one-lung ventilation (OLV). We sought to determine whether this new intubation maneuver using an endobronchial cuff pressure could be substituted for verification by fiberoptic bronchoscope (FOB) in most conditions requiring left-sided DLT. Seventy-nine patients requiring video-assisted thoracoscopic surgery for pneumothorax or mediastinal mass, or open thoracotomy for lung or esophageal cancer were enrolled in this study. We used 35F (n = 23), 37F (n = 51), or 39F (n = 5) disposable polyvinyl chloride DLTs (Broncho-Cath; Mallinckrodt Medical Ltd., Athlone, Ireland), depending on the height and gender of the patients. The DLTs were inserted deeply until resistance was felt. At that time, the pilot of the endobronchial cuff was connected to the Control-Inflator (VBM Medizintechnik GmbH, Sulz am Neckar, Germany) via a three-way stopcock. The bronchial balloon was inflated with 1.0-2.0 mL of air through the stop-cock until approximately 30 cm H2O of cuff pressure was obtained. The DLT was slowly withdrawn until the pressure of the Control-Inflator decreased to approximately half the peak pressure during the initial phase of removal. At that time, the bronchial balloon was deflated, and the DLT was advanced approximately 1.0 cm (1.5 cm for the 39F DLT); using FOB, its position was checked by an independent observer not involved in positioning the DLTs. The ideal position was defined as that in which the carina was located at the same level with the middle 5 mm between the proximal margin of the endobronchial balloon and the circumferential black mark. In 50 patients the position was ideal, and in 27 patients it was not ideal but was within the margin of the safety. There were only two failures. We conclude that if a FOB is unavailable or inapplicable, this simple and new maneuver may be used as a substitute during the positioning of DLTs. ⋯ The correct position of the double-lumen tube is vital for one-lung ventilation, which has been confirmed with a fiberoptic bronchoscope. We devised a simple maneuver to position the double-lumen tube correctly without a fiberoptic bronchoscope.
-
Anesthesia and analgesia · Jun 1998
The effect of hydroxyethyl starch on platelet aggregation in vitro.
The effect of hydroxyethyl starch (HES) on hemostasis seems to be minimal when it is used in recommended amounts. A number of studies have investigated the effect of HES on platelet function when administered in vivo, but there has been no study investigating the effect on the isolated platelet function when administered in vitro. A photometrical method to assess platelet function in platelet-rich plasma (approximately 250 x 10(9) platelets/L) was used with platelet aggregation induced using either collagen, epinephrine, adenosine diphosphate, or ristocetin. We found a dose-dependent decrease of platelet aggregation in vitro with either collagen or epinephrine, but not with adenosine diphosphate or ristocetin. However, the changes of HES on platelet aggregation were detected only in doses larger than those routinely used in the clinical setting. Therefore, we conclude that the influence of HES at the recommended doses on initial platelet aggregation may not be clinically relevant. ⋯ The effect of hydroxyethyl starch on platelet function and coagulation is discussed. This study showed no influence on platelets in clinically relevant doses in an in vitro model.